Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

RIV Capital Inc. (C:RIV)

Business Focus: Alternative Medicine

Feb 14, 2024 11:59 am ET
RIV Capital and Etain Open First New York Adult-Use Dispensary in White Plains
White Plains opening will mark Etain's first adult-use retail dispensaryThe move relocates Etain's prior medical-only retail dispensary from Yonkers to White Plains; which marks an important step to optimize Etain's retail portfolioThe new dispensary will honor Etain's legacy with a premium product menu and a curated experience that elevates fellow female-founded New York cannabis brandsWHITE PLAINS, N.Y., Feb. 14, 2024 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform w
Feb 14, 2024 11:59 am ET
RIV Capital and Etain Open First New York Adult-Use Dispensary in White Plains
White Plains opening will mark Etain's first adult-use retail dispensaryThe move relocates Etain's prior medical-only retail dispensary from Yonkers to White Plains; which marks an important step to optimize Etain's retail portfolioThe new dispensary will honor Etain's legacy with a premium product menu and a curated experience that elevates fellow female-founded New York cannabis brandsWHITE PLAINS, N.Y., Feb. 14, 2024 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate pla
Dec 08, 2023 11:24 am ET
Etain Obtains Approval to Commence Sales to New York's Adult-Use Market
Receives state regulatory approval from the New York Cannabis Control Board to transition to adult-use operations
Dec 08, 2023 11:24 am ET
Etain Obtains Approval to Commence Sales to New York's Adult-Use Market
Receives state regulatory approval from the New York Cannabis Control Board to transition to adult-use operations
Nov 29, 2023 06:59 am ET
RIV Capital Reports Financial Results for the Fiscal Quarter Ended September 30, 2023
Well positioned to execute on opportunities for growth with approximately $85 million in cash at period end
Nov 29, 2023 06:59 am ET
RIV Capital Reports Financial Results for the Fiscal Quarter Ended September 30, 2023
Well positioned to execute on opportunities for growth with approximately $85 million in cash at period end
Nov 15, 2023 04:01 pm ET
RIV Capital Sets Date for Financial Results for the Fiscal Quarter Ended September 30, 2023
TORONTO, Nov. 15, 2023 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, will report its financial results for the three and six months ended September 30, 2023 before markets open on Wednesday, November 29, 2023. As previously announced, due to a change in the Company's fiscal year end from March 31st to December 31st, the Company's current fiscal year is comprised of three quarters for
Nov 15, 2023 04:01 pm ET
RIV Capital Sets Date for Financial Results for the Fiscal Quarter Ended September 30, 2023
TORONTO, Nov. 15, 2023 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, will report its financial results for the three and six months ended September 30, 2023 before markets open on Wednesday, November 29, 2023. As previously announced, due to a change in the Company's fiscal year end from March 31st to December 31st, the Company's current fiscal year is comprised of three quarters for a tota
Nov 07, 2023 04:01 pm ET
RIV Capital Completes Expansion of New York Cultivation and Production Operations
Recently completed expansion of Chestertown facility triples current cannabis production capacity
Nov 07, 2023 04:01 pm ET
RIV Capital Completes Expansion of New York Cultivation and Production Operations
Recently completed expansion of Chestertown facility triples current cannabis production capacity
Sep 28, 2023 05:00 pm ET
RIV Capital Announces Results of Annual General and Special Meeting of Shareholders
TORONTO, Sept. 28, 2023 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, announced the voting results of its Annual General and Special Meeting of shareholders (the "Meeting") held today.
Sep 28, 2023 05:00 pm ET
RIV Capital Announces Results of Annual General and Special Meeting of Shareholders
TORONTO, Sept. 28, 2023 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, announced the voting results of its Annual General and Special Meeting of shareholders (the "Meeting") held today.
Aug 28, 2023 06:59 pm ET
RIV Capital Reports Financial Results for the Three Months Ended June 30th, 2023
Well capitalized to execute on the significant New York market opportunity and enter new geographies with $90.7 million in cash at period end
Aug 22, 2023 07:00 am ET
RIV Capital Sets Date for Financial Results for the Three Months Ended June 30th, 2023
TORONTO, Aug. 22, 2023 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, will report its financial results for the first quarter ended June 30, 2023 after markets close on Monday, August 28, 2023. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the quarter will be available on the Company's profile on SEDAR+ at www.sedarpl
Aug 01, 2023 05:00 pm ET
Etain Receives Regulatory Approval for Flagship Facility in Buffalo, New York
 The Buffalo cultivation and manufacturing facility is expected to be completed by CQ3 2024
Aug 01, 2023 05:00 pm ET
Etain Receives Regulatory Approval for Flagship Facility in Buffalo, New York
 The Buffalo cultivation and manufacturing facility is expected to be completed by CQ3 2024
Jun 14, 2023 08:04 pm ET
RIV Capital Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Ends fiscal year with approximately $97.9 million of cash and short-term investments, with more than sufficient liquidity to capitalize on upcoming New York transition and explore opportunities beyond the state
Jun 14, 2023 08:04 pm ET
RIV Capital Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Ends fiscal year with approximately $97.9 million of cash and short-term investments, with more than sufficient liquidity to capitalize on upcoming New York transition and explore opportunities beyond the state
Jun 08, 2023 05:00 pm ET
RIV Capital Sets Date for Fourth Quarter and Fiscal Year 2023 Financial Results
TORONTO, June 8, 2023 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, will report its financial results for the fourth quarter and fiscal year ended March 31, 2023 after markets close on Wednesday, June 14, 2023. The Company's audited consolidated financial statements and management's discussion and analysis for the three months and fiscal year ended March 31, 2023 will be available on the Co
Jun 08, 2023 05:00 pm ET
RIV Capital Sets Date for Fourth Quarter and Fiscal Year 2023 Financial Results
TORONTO, June 8, 2023 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, will report its financial results for the fourth quarter and fiscal year ended March 31, 2023 after markets close on Wednesday, June 14, 2023. The Company's audited consolidated financial statements and management's discussion and analysis for the three months and fiscal year ended March 31, 2023 will be available on
May 12, 2023 08:40 am ET
May 12, 2023 08:40 am ET
Mar 01, 2023 07:53 am ET
RIV Capital Reports Fiscal Third Quarter 2023 Financial Results
Announces executive changes to drive execution in New York State and beyond; Company to conduct comprehensive search for a new CEO in near term
Feb 23, 2023 11:47 am ET
IIROC Trade Resumption - RIV
VANCOUVER, BC, Feb. 23, 2023 /CNW/ - Trading resumes in:
Feb 23, 2023 11:40 am ET
RIV Capital Settles Application Initiated by JW Asset Management
TORONTO, Feb. 23, 2023 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm focused on building a leading multistate platform with the strongest portfolio of cannabis brands in key strategic markets across the United States, today announced that it has entered into a settlement agreement that has resulted in JW Asset Management, LLC ("JWAM") consenting to the dismissal of its application related to the Company's acquisition of Etain, LLC and Etain IP, LLC.
Feb 23, 2023 11:40 am ET
RIV Capital Settles Application Initiated by JW Asset Management
TORONTO, Feb. 23, 2023 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm focused on building a leading multistate platform with the strongest portfolio of cannabis brands in key strategic markets across the United States, today announced that it has entered into a settlement agreement that has resulted in JW Asset Management, LLC ("JWAM") consenting to the dismissal of its application related to the Company's acquisition of Etain, LLC and Etain IP, LLC.
Feb 23, 2023 10:09 am ET
IIROC Trading Halt - RIV
VANCOUVER, BC, Feb. 23, 2023 /CNW/ - The following issues have been halted by IIROC:
Feb 22, 2023 07:00 am ET
RIV Capital Sets Date for Third Quarter 2023 Financial Results
TORONTO, Feb. 22, 2023 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, will report its financial results for the third quarter ended December 31, 2022 before markets open on Wednesday, March 1, 2023. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the quarter will be available on the Company's profile on SEDAR at www.sed
Jan 09, 2023 04:31 pm ET
RIV Capital Schedules Special Meeting of Shareholders in Response to Shareholder Requisition
TORONTO, Jan. 9, 2023 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), a cannabis packaged goods company with a focus on establishing one of the strongest portfolios of brands in key strategic U.S. markets, today announced that it has scheduled a special meeting of its shareholders for June 6, 2023 at 10:00 a.m. EDT (the "Special Meeting"), in response to the previously announced shareholder requisition from funds that are controlled or directed by JW Asset Management, LLC ("JWAM"). As previously announced, JWAM has requisitioned the Special Meeting t
Jan 09, 2023 04:31 pm ET
RIV Capital Schedules Special Meeting of Shareholders in Response to Shareholder Requisition
TORONTO, Jan. 9, 2023 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), a cannabis packaged goods company with a focus on establishing one of the strongest portfolios of brands in key strategic U.S. markets, today announced that it has scheduled a special meeting of its shareholders for June 6, 2023 at 10:00 a.m. EDT (the "Special Meeting"), in response to the previously announced shareholder requisition from funds that are controlled or directed by JW Asset Management, LLC ("JWAM"). As previously announced, JWAM has requisitioned the Special Meeting to, amon
Dec 21, 2022 07:06 am ET
RIV Capital Acknowledges Receipt of Shareholder Meeting Requisition
TORONTO, Dec. 21, 2022 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) today announced that its board of directors (the "Board") received a shareholder requisition on December 20, 2022, requesting that the Company call a special meeting of RIV Capital's shareholders for the purpose of, among other things, electing five new directors to the Board, just three months after shareholders elected all seven of the Company's nominees at its Annual General Meeting.
Dec 21, 2022 07:06 am ET
RIV Capital Acknowledges Receipt of Shareholder Meeting Requisition
TORONTO, Dec. 21, 2022 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) today announced that its board of directors (the "Board") received a shareholder requisition on December 20, 2022, requesting that the Company call a special meeting of RIV Capital's shareholders for the purpose of, among other things, electing five new directors to the Board, just three months after shareholders elected all seven of the Company's nominees at its Annual General Meeting.
Dec 20, 2022 04:07 pm ET
RIV Capital's Largest Shareholder, JW Asset Management, Requisitions Special Meeting to Address Necessary Leadership Changes
Immediate Board refresh is needed to preserve shareholder value and maximize the Company's potential Current leadership team recklessly pursued and closed on overpriced and risky acquisition without shareholder vote or fairness opinion Transactions with related parties and lack of independent oversight need to be addressed for Company to be successful over timeNEW YORK, Dec. 20, 2022 /CNW/ - JW Asset Management, LLC (the "Concerned Shareholder"), the largest shareholder of RIV Capital Inc. (CSE: RIV) (the "Company" or "RIV Capital"), controlling and directing approximately 19.77% of the issu
Dec 15, 2022 03:33 pm ET
RIV Capital Completes Final Closing of Previously Announced Etain Transaction
Transformative transaction establishes a foundation for the Company's platform as Etain is one of only 10 vertically integrated operators in New York
Dec 15, 2022 03:33 pm ET
RIV Capital Completes Final Closing of Previously Announced Etain Transaction
Transformative transaction establishes a foundation for the Company's platform as Etain is one of only 10 vertically integrated operators in New York
Nov 29, 2022 07:31 am ET
RIV Capital Reports Fiscal Second Quarter 2023 Financial Results
- Receives all regulatory approvals for the final closing of the previously announced Etain Transaction, which is expected to occur by year end
Nov 29, 2022 07:31 am ET
RIV Capital Reports Fiscal Second Quarter 2023 Financial Results
- Receives all regulatory approvals for the final closing of the previously announced Etain Transaction, which is expected to occur by year end
Nov 22, 2022 06:30 am ET
RIV Capital Sets Date for Second Quarter 2023 Financial Results
TORONTO, Nov. 22, 2022 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, will report its financial results for the second quarter ended September 30, 2022 before markets open on Tuesday, November 29, 2022. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the quarter will be available on the Company's profile on SEDAR
Nov 22, 2022 06:30 am ET
RIV Capital Sets Date for Second Quarter 2023 Financial Results
TORONTO, Nov. 22, 2022 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, will report its financial results for the second quarter ended September 30, 2022 before markets open on Tuesday, November 29, 2022. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the quarter will be available on the Company's profile on SEDAR at www
Nov 21, 2022 12:42 pm ET
New York State Cannabis Control Board Approves Change of Control of Etain LLC's Vertically Integrated License
All required regulatory approvals to complete RIV's Etain transaction have been obtained, with final closing expected by the end of Q4 2022
Nov 21, 2022 12:42 pm ET
New York State Cannabis Control Board Approves Change of Control of Etain LLC's Vertically Integrated License
All required regulatory approvals to complete RIV's Etain transaction have been obtained, with final closing expected by the end of Q4 2022
Nov 09, 2022 09:20 am ET
RIV Capital Issues Statement on New York's Gubernatorial Election
TORONTO, Nov. 9, 2022 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, issued the following statement on New York's gubernatorial election.
Nov 09, 2022 09:20 am ET
RIV Capital Issues Statement on New York's Gubernatorial Election
TORONTO, Nov. 9, 2022 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multistate platform with one of the strongest portfolios of brands in key strategic U.S. markets, issued the following statement on New York's gubernatorial election.
Sep 29, 2022 05:00 pm ET
RIV Capital Announces Results of Annual General Meeting of Shareholders
TORONTO, Sept. 29, 2022 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm focused on building a leading multistate platform with the strongest portfolio of cannabis brands in key strategic markets across the United States, announced the voting results of its Annual General Meeting of shareholders (the "Meeting") held today.
Sep 29, 2022 05:00 pm ET
RIV Capital Announces Results of Annual General Meeting of Shareholders
TORONTO, Sept. 29, 2022 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm focused on building a leading multistate platform with the strongest portfolio of cannabis brands in key strategic markets across the United States, announced the voting results of its Annual General Meeting of shareholders (the "Meeting") held today.
Sep 26, 2022 07:30 am ET
RIV Capital Reminds Shareholders to Vote FOR its Board Nominees
With RIV Capital's highly qualified Board nominees, the Company is poised to create shareholder value and establish itself as a leader in the industry.Leading independent proxy advisory firms, ISS and Glass Lewis, have both recommended that shareholders vote FOR RIV Capital's Board nominees.Vote FOR RIV Capital's Board nominees before the deadline of 10:00 a.m. (EDT) on September 27, 2022. For help voting, please contact Kingsdale Advisors at 1-877-659-1821 (toll free in North America), or at 1-416-867-2272 (collect outside North America), or by email at [email protected]
Sep 26, 2022 07:30 am ET
RIV Capital Reminds Shareholders to Vote FOR its Board Nominees
With RIV Capital's highly qualified Board nominees, the Company is poised to create shareholder value and establish itself as a leader in the industry.Leading independent proxy advisory firms, ISS and Glass Lewis, have both recommended that shareholders vote FOR RIV Capital's Board nominees.Vote FOR RIV Capital's Board nominees before the deadline of 10:00 a.m. (EDT) on September 27, 2022. For help voting, please contact Kingsdale Advisors at 1-877-659-1821 (toll free in North America), or at 1-416-867-2272 (collect outside North America), or by email at [email protected]
Sep 15, 2022 06:28 pm ET
CSE Bulletin: INDEX - CSE 25 INDEX QUARTERLY REBALANCING
Toronto, Ontario--(Newsfile Corp. - Le 15 septembre 2022/September 2022) - The quarterly rebalancing of the CSE 25 Index will result in the following changes, effective after the close on Friday, September 16, 2022.
Sep 14, 2022 05:00 pm ET
Independent Proxy Advisory Firm ISS Recommends Shareholders Vote FOR RIV Capital's Board
Institutional Shareholder Services joins Glass Lewis in support of all seven of the Company's Board nominees.RIV Capital's Board nominees are well equipped with the relevant industry expertise, experience and qualifications to execute on RIV Capital's strategic vision to become a leader in the cannabis market.Vote FOR RIV Capital's Board nominees well before the deadline of 10:00 a.m. (EDT) on September 27, 2022. For help voting, please contact Kingsdale Advisors at 1-877-659-1821 (toll free in North America), or at 1-416-867-2272 (collect outside North America), or by email at contactus@kin
Sep 14, 2022 05:00 pm ET
Independent Proxy Advisory Firm ISS Recommends Shareholders Vote FOR RIV Capital's Board
Institutional Shareholder Services joins Glass Lewis in support of all seven of the Company's Board nominees.RIV Capital's Board nominees are well equipped with the relevant industry expertise, experience and qualifications to execute on RIV Capital's strategic vision to become a leader in the cannabis market.Vote FOR RIV Capital's Board nominees well before the deadline of 10:00 a.m. (EDT) on September 27, 2022. For help voting, please contact Kingsdale Advisors at 1-877-659-1821 (toll free in North America), or at 1-416-867-2272 (collect outside North America), or by email at contactus@kin
Sep 07, 2022 05:19 pm ET
Independent Proxy Advisory Firm Glass Lewis Endorses RIV Capital's Board of Directors
Independent proxy advisory firm Glass Lewis recommends shareholders vote FOR RIV Capital's highly qualified Board nominees.RIV Capital's visionary and highly experienced Board nominees bring diverse views, financial and capital market experience, and an understanding of the cannabis market in both Canada and the U.S.; they are committed to delivering future growth and further enhancing shareholder value.Vote FOR RIV Capital's Board nominees well before the deadline of 10:00 a.m. (EDT) on September 27, 2022. For help voting, please contact Kingsdale Advisors at 1-877-659-1821 (toll free in No
Sep 07, 2022 05:19 pm ET
Independent Proxy Advisory Firm Glass Lewis Endorses RIV Capital's Board of Directors
Independent proxy advisory firm Glass Lewis recommends shareholders vote FOR RIV Capital's highly qualified Board nominees.RIV Capital's visionary and highly experienced Board nominees bring diverse views, financial and capital market experience, and an understanding of the cannabis market in both Canada and the U.S.; they are committed to delivering future growth and further enhancing shareholder value.Vote FOR RIV Capital's Board nominees well before the deadline of 10:00 a.m. (EDT) on September 27, 2022. For help voting, please contact Kingsdale Advisors at 1-877-659-1821 (toll free in No
Aug 30, 2022 07:45 am ET
RIV Capital Files Circular for Annual General Meeting
RIV Capital is on the right track to reap the benefits of its strategic pivot into the U.S. cannabis market. The Company is well situated to become a leading cannabis operator.Vote FOR RIV Capital's board of directors well before the deadline of 10:00 a.m. (EDT) on September 27, 2022. For help voting, please contact Kingsdale Advisors at 1-877-659-1821 (toll free in North America), or at 1-416-867-2272 (collect outside North America), or by email at [email protected] are encouraged to read the complete letter and management information circular, which are available
Aug 30, 2022 07:45 am ET
RIV Capital Files Circular for Annual General Meeting
RIV Capital is on the right track to reap the benefits of its strategic pivot into the U.S. cannabis market. The Company is well situated to become a leading cannabis operator.Vote FOR RIV Capital's board of directors well before the deadline of 10:00 a.m. (EDT) on September 27, 2022. For help voting, please contact Kingsdale Advisors at 1-877-659-1821 (toll free in North America), or at 1-416-867-2272 (collect outside North America), or by email at [email protected] are encouraged to read the complete letter and management information circular, which are available
Aug 29, 2022 06:20 pm ET
RIV Capital Reports First Quarter 2023 Financial Results
Company working with Etain, LLC to scale infrastructure and processes ahead of license transfer and anticipated launch of New York adult-use sales
Aug 29, 2022 06:20 pm ET
RIV Capital Reports First Quarter 2023 Financial Results
Company working with Etain, LLC to scale infrastructure and processes ahead of license transfer and anticipated launch of New York adult-use sales
Aug 23, 2022 05:01 pm ET
RIV Capital Signs Lease for Flagship Cannabis Cultivation and Manufacturing Facility in Buffalo, New York
TORONTO, Aug. 23, 2022 /CNW/ - RIV Capital Inc. (the "Company") (CSE: RIV) (OTC: CNPOF), a cannabis packaged goods company with a focus on establishing one of the strongest portfolios of brands in key strategic U.S. markets, acting through its wholly owned indirect subsidiary, RIV Capital US Real Estate LLC ("RIV Real Estate", together with the Company, collectively, "RIV Capital"), and Etain, LLC ("Etain") announced that RIV Capital has entered into a lease agreement with Zephyr, a leading California-based developer, for the development and operation of a planned new flagship cannabis culti
Aug 23, 2022 05:01 pm ET
RIV Capital Signs Lease for Flagship Cannabis Cultivation and Manufacturing Facility in Buffalo, New York
TORONTO, Aug. 23, 2022 /PRNewswire/ - RIV Capital Inc. (the "Company") (CSE: RIV) (OTC: CNPOF), a cannabis packaged goods company with a focus on establishing one of the strongest portfolios of brands in key strategic U.S. markets, acting through its wholly owned indirect subsidiary, RIV Capital US Real Estate LLC ("RIV Real Estate", together with the Company, collectively, "RIV Capital"), and Etain, LLC ("Etain") announced that RIV Capital has entered into a lease agreement with Zephyr, a leading California-based developer, for the development and operation of a planned new flagship cannabi
Aug 23, 2022 05:00 pm ET
RIV Capital Sets Date for First Quarter 2023 Financial Results
TORONTO, Aug. 23, 2022 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), a cannabis packaged goods company with a focus on establishing one of the strongest portfolios of brands in key strategic U.S. markets, will report its financial results for the first quarter ended June 30, 2022, after markets close on Monday, August 29, 2022. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the quarter will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website
Aug 23, 2022 05:00 pm ET
RIV Capital Sets Date for First Quarter 2023 Financial Results
TORONTO, Aug. 23, 2022 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), a cannabis packaged goods company with a focus on establishing one of the strongest portfolios of brands in key strategic U.S. markets, will report its financial results for the first quarter ended June 30, 2022, after markets close on Monday, August 29, 2022. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the quarter will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's w
Jun 13, 2022 07:00 am ET
RIV Capital Reports Fourth Quarter and Fiscal Year 2022 Financial Results
Previously Announced Acquisition of Etain Represents Initial Step to Becoming Licensed, Vertically-Integrated U.S. Cannabis Operator
Jun 13, 2022 07:00 am ET
RIV Capital Reports Fourth Quarter and Fiscal Year 2022 Financial Results
Previously Announced Acquisition of Etain Represents Initial Step to Becoming Licensed, Vertically-Integrated U.S. Cannabis Operator
Jun 07, 2022 07:00 am ET
RIV Capital sets date for fourth quarter and fiscal year 2022 financial results
TORONTO, June 7, 2022 /CNW/ - RIV Capital Inc. (the "Company" or "RIV Capital") (CSE: RIV) (OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2022 before markets open on Monday, June 13, 2022. The Company's audited consolidated financial statements and management's discussion and analysis for the three months and year ended March 31, 2022 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.rivcapital.com/investors.
Jun 07, 2022 07:00 am ET
RIV Capital sets date for fourth quarter and fiscal year 2022 financial results
TORONTO, June 7, 2022 /PRNewswire/ - RIV Capital Inc. (the "Company" or "RIV Capital") (CSE: RIV) (OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2022 before markets open on Monday, June 13, 2022. The Company's audited consolidated financial statements and management's discussion and analysis for the three months and year ended March 31, 2022 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.rivcapital.com/investors.
May 24, 2022 08:00 am ET
RIV Capital announces receipt of application in connection with Etain acquisition
TORONTO, May 24, 2022 /PRNewswire/ - RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) ("RIV Capital" or the "Company") today announced that it had received notice of an Ontario Superior Court of Justice application by JW Asset Management ("JWAM") in connection with the Company's process regarding its acquisition of ownership and control of Etain, LLC and Etain IP LLC, owners and operators of legally licensed cannabis cultivation and retail dispensaries in the state of New York (the "Etain Acquisition").
May 24, 2022 08:00 am ET
RIV Capital announces receipt of application in connection with Etain acquisition
TORONTO, May 24, 2022 /CNW/ - RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) ("RIV Capital" or the "Company") today announced that it had received notice of an Ontario Superior Court of Justice application by JW Asset Management ("JWAM") in connection with the Company's process regarding its acquisition of ownership and control of Etain, LLC and Etain IP LLC, owners and operators of legally licensed cannabis cultivation and retail dispensaries in the state of New York (the "Etain Acquisition").
Apr 22, 2022 05:06 pm ET
RIV Capital announces initial closing of Etain acquisition
TORONTO, April 22, 2022 /CNW/ - RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) ("RIV Capital" or the "Company") today announced completion of the initial closing (the "Initial Closing") of its previously disclosed transaction involving Etain, LLC and Etain IP LLC, owners and operators of legally licensed cannabis cultivation and retail dispensaries in the state of New York (the "Etain Acquisition"). Pursuant to the Initial Closing, RIV Capital is acquiring the non-regulated portion of the Etain companies for approximately US$198 million through a combination of cash and newly issued Class A common
Apr 22, 2022 05:06 pm ET
RIV Capital announces initial closing of Etain acquisition
TORONTO, April 22, 2022 /PRNewswire/ - RIV Capital Inc. (CSE: RIV) (OTC: CNPOF) ("RIV Capital" or the "Company") today announced completion of the initial closing (the "Initial Closing") of its previously disclosed transaction involving Etain, LLC and Etain IP LLC, owners and operators of legally licensed cannabis cultivation and retail dispensaries in the state of New York (the "Etain Acquisition"). Pursuant to the Initial Closing, RIV Capital is acquiring the non-regulated portion of the Etain companies for approximately US$198 million through a combination of cash and newly issued Class A
Mar 30, 2022 07:00 am ET
RIV Capital to acquire New York-based Etain, names new CEO to lead entry and expansion in U.S. cannabis market
Transformative transaction will include one of only 10 vertically integrated licences in New York and four active dispensaries with plans to bolster operations in advance of adult-use market
Mar 30, 2022 07:00 am ET
RIV Capital to acquire New York-based Etain, names new CEO to lead entry and expansion in U.S. cannabis market
Transformative transaction will include one of only 10 vertically integrated licences in New York and four active dispensaries with plans to bolster operations in advance of adult-use market
Mar 01, 2022 06:00 am ET
RIV Capital reports third quarter fiscal year 2022 financial results
Strongly Positioned with Approximately US$319 million1 in Cash to Launch U.S. Platform
Mar 01, 2022 06:00 am ET
RIV Capital reports third quarter fiscal year 2022 financial results
Strongly Positioned with Approximately US$319 million1 in Cash to Launch U.S. Platform
Feb 24, 2022 04:00 pm ET
RIV CAPITAL SETS DATE FOR THIRD QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS
TORONTO, Feb. 24, 2022 /CNW/ - RIV Capital Inc. (the "Company" or "RIV Capital") (CSE: RIV) (OTC: CNPOF) will report its financial results for the quarter ended December 31, 2021 ("Q3 2022") before markets open on Tuesday, March 1, 2022. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the three and nine months ended December 31, 2021 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.rivcapital.com/investors.
Feb 24, 2022 04:00 pm ET
RIV CAPITAL SETS DATE FOR THIRD QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS
TORONTO, Feb. 24, 2022 /PRNewswire/ - RIV Capital Inc. (the "Company" or "RIV Capital") (CSE: RIV) (OTC: CNPOF) will report its financial results for the quarter ended December 31, 2021 ("Q3 2022") before markets open on Tuesday, March 1, 2022. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the three and nine months ended December 31, 2021 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.rivcapital.com/investors.
Nov 18, 2021 06:00 am ET
RIV Capital Reports Second Quarter Fiscal Year 2022 Financial Results
Strategic investment of US$150 million by The Hawthorne Collective highlights quarter
Nov 18, 2021 06:00 am ET
RIV Capital Reports Second Quarter Fiscal Year 2022 Financial Results
Strategic investment of US$150 million by The Hawthorne Collective highlights quarter
Nov 04, 2021 07:00 am ET
RIV Capital Sets Date For Second Quarter Fiscal Year 2022 Financial Results
TORONTO, Nov. 4, 2021 /PRNewswire/ - RIV Capital Inc. (the "Company" or "RIV Capital") (CSE: RIV) (OTC: CNPOF) will report its financial results for the quarter ended September 30, 2021 ("Q2 2022") before markets open on Thursday, November 18, 2021. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the three and six months ended September 30, 2021 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.rivcapital.com/investors.
Nov 04, 2021 07:00 am ET
RIV Capital Sets Date For Second Quarter Fiscal Year 2022 Financial Results
TORONTO, Nov. 4, 2021 /CNW/ - RIV Capital Inc. (the "Company" or "RIV Capital") (CSE: RIV) (OTC: CNPOF) will report its financial results for the quarter ended September 30, 2021 ("Q2 2022") before markets open on Thursday, November 18, 2021. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the three and six months ended September 30, 2021 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.rivcapital.com/investors.
Sep 30, 2021 05:00 pm ET
RIV Capital Announces Results of Annual General and Special Meeting of Shareholders
TORONTO, Sept. 30, 2021 /PRNewswire/ - RIV Capital Inc. (the "Company") (CSE: RIV) (OTC: CNPOF) announced the voting results of its annual general and special meeting of shareholders (the "Meeting") held today.
Sep 30, 2021 05:00 pm ET
RIV Capital Announces Results of Annual General and Special Meeting of Shareholders
TORONTO, Sept. 30, 2021 /CNW/ - RIV Capital Inc. (the "Company") (CSE: RIV) (OTC: CNPOF) announced the voting results of its annual general and special meeting of shareholders (the "Meeting") held today.
Sep 17, 2021 05:32 am ET
CSE Bulletin: Index - CSE 25 Index Quarterly Rebalancing
Toronto, Ontario--(Newsfile Corp. - Le 16 septembre 2021/September 2021) - The quarterly rebalancing of the CSE 25 Index will result in the following changes, effective after the close on Friday, September 17, 2021.
Sep 13, 2021 07:37 am ET
RIV Capital Receives ~$6.5 Million Upon Termination of PharmHouse's CCAA Proceedings
TORONTO, Sept. 13, 2021 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) today announced that it has received a cash distribution of approximately $6.5 million and that termination of PharmHouse Inc.'s ("PharmHouse") proceedings under the Companies' Creditors Arrangement Act (Canada) (the "CCAA Proceedings") and PharmHouse's assignment into bankruptcy under the Bankruptcy and Insolvency Act (Canada) is expected imminently. Pursuant to orders granted by the Ontario Superior Court of Justice (Commercial List) in the CCAA Proceedings, RIV Capital was entitled to
Sep 13, 2021 07:37 am ET
RIV Capital Receives ~$6.5 Million Upon Termination of PharmHouse's CCAA Proceedings
TORONTO, Sept. 13, 2021 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) today announced that it has received a cash distribution of approximately $6.5 million and that termination of PharmHouse Inc.'s ("PharmHouse") proceedings under the Companies' Creditors Arrangement Act (Canada) (the "CCAA Proceedings") and PharmHouse's assignment into bankruptcy under the Bankruptcy and Insolvency Act (Canada) is expected imminently. Pursuant to orders granted by the Ontario Superior Court of Justice (Commercial List) in the CCAA Proceedings, RIV Capital was enti
Sep 09, 2021 05:00 pm ET
RIV Capital Announces AGM Date
TORONTO, Sept. 9, 2021 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) will hold its annual general and special meeting (the "Meeting") of shareholders of the Company ("Shareholders") on September 30, 2021 at 10 a.m. (EDT). Electronic copies of all materials related to the Meeting can be found on the Company's profile on the System for Electronic Document Analysis and Retrieval or on its website at www.rivcapital.com/investors.
Sep 09, 2021 05:00 pm ET
RIV Capital Announces AGM Date
TORONTO, Sept. 9, 2021 /PRNewswire/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF) will hold its annual general and special meeting (the "Meeting") of shareholders of the Company ("Shareholders") on September 30, 2021 at 10 a.m. (EDT). Electronic copies of all materials related to the Meeting can be found on the Company's profile on the System for Electronic Document Analysis and Retrieval or on its website at www.rivcapital.com/investors.
Aug 20, 2021 12:00 pm ET
CSE Bulletin: New Listing - RIV Capital Inc. (RIV)
Toronto, Ontario--(Newsfile Corp. - Le 20 août/August 2021) - The common shares of RIV Capital Inc. have been approved for listing on the CSE.
Aug 16, 2021 07:00 am ET
RIV Capital Reports First Quarter Fiscal Year 2022 Financial Results
Cash balance of $212.5 million as at June 30th after completion of multiple monetization events during the quarter
Aug 16, 2021 07:00 am ET
RIV Capital Reports First Quarter Fiscal Year 2022 Financial Results
Cash balance of $212.5 million as at June 30th after completion of multiple monetization events during the quarter
Aug 10, 2021 07:10 am ET
ScottsMiracle-Gro Announces Creation of New Investment Entity to Enable Investments in the Cannabis Industry
The Scotts Miracle-Gro Company (NYSE: SMG) announced today the creation of a newly formed subsidiary, The Hawthorne Collective, which will focus on strategic minority investments in areas of the cannabis industry not currently pursued by The...
Aug 10, 2021 07:00 am ET
RIV Capital Announces US$150 Million Strategic Investment by The Hawthorne Collective, a Subsidiary of The Scotts Miracle-Gro Company
The Hawthorne Collective to purchase convertible note from RIV Capital to further RIV Capital's U.S. strategy
Aug 10, 2021 07:00 am ET
RIV Capital Announces US$150 Million Strategic Investment by The Hawthorne Collective, a Subsidiary of The Scotts Miracle-Gro Company
The Hawthorne Collective to purchase convertible note from RIV Capital to further RIV Capital's U.S. strategy
Aug 03, 2021 07:00 am ET
RIV Capital Sets Date for First Quarter Fiscal Year 2022 Financial Results
TORONTO, Aug. 3, 2021 /CNW/ - RIV Capital Inc. (the "Company" or "RIV Capital") (TSX: RIV) (OTC: CNPOF) will report its financial results for the quarter ended June 30, 2021 ("Q1 2022") before markets open on Monday, August 16, 2021. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the three months ended June 30, 2021 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.rivcapital.com/investors.
Aug 03, 2021 07:00 am ET
RIV Capital Sets Date for First Quarter Fiscal Year 2022 Financial Results
TORONTO, Aug. 3, 2021 /PRNewswire/ - RIV Capital Inc. (the "Company" or "RIV Capital") (TSX: RIV) (OTC: CNPOF) will report its financial results for the quarter ended June 30, 2021 ("Q1 2022") before markets open on Monday, August 16, 2021. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis for the three months ended June 30, 2021 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.rivcapital.com/investors.
Jun 03, 2021 07:00 am ET
RIV Capital Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Comprehensive income of $67.3 million for fiscal year
Jun 02, 2021 07:00 am ET
RIV Capital Sells New Brunswick Property for $4 Million
TORONTO, June 2, 2021 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (TSX: RIV) (OTC: CNPOF) today announced that it has closed an agreement with The Tweed Tree Lot Inc. ("TTL"), a subsidiary of Canopy Growth Corporation ("Canopy Growth"), to sell a property located in Fredericton, New Brunswick in exchange for a cash payment of $4 million.
Jun 01, 2021 07:00 am ET
RIV Capital Portfolio Company ZeaKal Unveils Breakthrough High-Oil Hemp Results
ZeaKal's novel PhotoSeed trait boosts hemp biomass oil output by up to 50%
May 19, 2021 07:00 am ET
RIV Capital Sets Date for Fourth Quarter and Fiscal Year 2021 Financial Results
TORONTO, May 19, 2021 /CNW/ - RIV Capital Inc. (the "Company" or "RIV Capital") (TSX: RIV) (OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2021 before markets open on Thursday, June 3, 2021. The Company's audited consolidated financial statements and management's discussion and analysis for the three and twelve months ended March 31, 2021 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.rivcapital.com/investors.
May 17, 2021 07:00 am ET
PharmHouse Closes Sale of Greenhouse Facility
RIV Capital settles guarantee obligations pursuant to PharmHouse's Credit Facility
May 12, 2021 01:05 pm ET
RAMM Pharma to Acquire 100% of Leading Vertically Integrated European Cannabis Company Canapar Corp.
RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Company has entered into a...
Mar 11, 2021 04:00 pm ET
Court Approves Pharmhouse's Asset Purchase Agreement
RIV Capital will make payment to reduce estimated liability with respect to guarantee of PharmHouse Credit Facility by $25.0 million
Feb 23, 2021 08:22 am ET
RIV Capital Closes Plan of Arrangement Involving Canopy Growth, Paving Way for Entry Into U.S. Market
TORONTO, Feb. 23, 2021 /PRNewswire/ - RIV Capital Inc. (formerly Canopy Rivers Inc.) ("RIV Capital" or the "Company") (TSX: RIV) (OTC: CNPOF)  is pleased to announce the completion of the previously announced plan of arrangement (the "Arrangement") involving Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC).
Feb 23, 2021 08:22 am ET
RIV Capital Closes Plan of Arrangement Involving Canopy Growth, Paving Way for Entry Into U.S. Market
TORONTO, Feb. 23, 2021 /CNW/ - RIV Capital Inc. (formerly Canopy Rivers Inc.) ("RIV Capital" or the "Company") (TSX: RIV) (OTC: CNPOF)  is pleased to announce the completion of the previously announced plan of arrangement (the "Arrangement") involving Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC).
Feb 16, 2021 04:00 pm ET
Rivers Shareholders Approve Plan of Arrangement with Canopy Growth
TORONTO, Feb. 16, 2021 /CNW/ - Canopy Rivers Inc. ("Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) is pleased to announce that its shareholders voted today to approve the previously announced plan of arrangement (the "Arrangement") involving Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC). 
Feb 16, 2021 04:00 pm ET
Rivers Shareholders Approve Plan of Arrangement with Canopy Growth
TORONTO, Feb. 16, 2021 /PRNewswire/ - Canopy Rivers Inc. ("Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) is pleased to announce that its shareholders voted today to approve the previously announced plan of arrangement (the "Arrangement") involving Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC). 
Feb 10, 2021 06:00 am ET
Canopy Rivers Reports Third Quarter Fiscal Year 2021 Financial Results
Comprehensive income of $82.2 million driven by significant increase in value of investment in TerrAscend
Feb 10, 2021 06:00 am ET
Canopy Rivers Reports Third Quarter Fiscal Year 2021 Financial Results
Comprehensive income of $82.2 million driven by significant increase in value of investment in TerrAscend
Jan 27, 2021 06:00 am ET
Canopy Rivers Sets Filing Date For Q3 Fiscal Year 2021 Financial Results
TORONTO, Jan. 27, 2021 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will report its third quarter fiscal year 2021 financial results before markets open on February 10, 2021. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis of financial results for the three and nine months ended December 31, 2020 will be available on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com
Jan 27, 2021 06:00 am ET
Canopy Rivers Sets Filing Date For Q3 Fiscal Year 2021 Financial Results
TORONTO, Jan. 27, 2021 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will report its third quarter fiscal year 2021 financial results before markets open on February 10, 2021. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis of financial results for the three and nine months ended December 31, 2020 will be available on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/invest
Jan 20, 2021 05:48 pm ET
Canopy Rivers Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement
TORONTO, Jan. 20, 2021 /PRNewswire/ - Canopy Rivers Inc. ("Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) today filed and mailed the management information circular (the "Circular") and related materials in connection with the special meeting (the "Meeting") of shareholders to be held virtually on February 16, 2021 at 10:00 a.m. (Toronto time).
Jan 20, 2021 05:48 pm ET
Canopy Rivers Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement
TORONTO, Jan. 20, 2021 /CNW/ - Canopy Rivers Inc. ("Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) today filed and mailed the management information circular (the "Circular") and related materials in connection with the special meeting (the "Meeting") of shareholders to be held virtually on February 16, 2021 at 10:00 a.m. (Toronto time).
Jan 20, 2021 09:48 am ET
Canapar Welcomes RAMM Pharma as Strategic Shareholder; Closes $6,427,000 Financing
Canapar Corp. (“Canapar”) and RAMM Pharma Corp. (including its wholly owned subsidiaries, "RAMM") (CSE: RAMM) are pleased to announce they have entered into a strategic partnership, combining Canapar’s hemp-derived cannabidiol (CBD) extraction...
Dec 30, 2020 05:26 pm ET
RAMM Pharma Enters European Cannabis Market with Strategic Investment in Canapar Corp.
RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical and other cannabis-based products, is pleased to announce that the Company has acquired 49% of...
Dec 30, 2020 04:00 pm ET
Canopy Rivers Sells Interest in Italy-Based Canapar
TORONTO, Dec. 30, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF), through its wholly-owned subsidiary, Canopy Rivers Corporation, has entered into a definitive share purchase agreement (the "Share Purchase Agreement"), effective as of December 30, 2020, with RAMM Pharma Corp. ("RAMM") (CSE: RAMM), pursuant to which the Company has sold its 49% common equity interest in Canapar Corp. ("Canapar") to RAMM for consideration of up to $9.0 million (the "Transaction").
Dec 30, 2020 04:00 pm ET
Canopy Rivers Sells Interest in Italy-Based Canapar
TORONTO, Dec. 30, 2020 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF), through its wholly-owned subsidiary, Canopy Rivers Corporation, has entered into a definitive share purchase agreement (the "Share Purchase Agreement"), effective as of December 30, 2020, with RAMM Pharma Corp. ("RAMM") (CSE: RAMM), pursuant to which the Company has sold its 49% common equity interest in Canapar Corp. ("Canapar") to RAMM for consideration of up to $9.0 million (the "Transaction").
Dec 21, 2020 08:18 am ET
IIROC Trade Resumption - RIV
TORONTO, Dec. 21, 2020 /CNW/ - Trading resumes in:
Dec 21, 2020 08:15 am ET
IIROC Trading Halt - RIV
TORONTO, Dec. 21, 2020 /CNW/ - The following issues have been halted by IIROC:
Dec 21, 2020 08:00 am ET
Canopy Rivers to Monetize Certain Portfolio Assets for Total Transaction Value of Approximately $297 Million and Eliminate Dual Class Share Structure Pursuant to Agreement with Canopy Growth, Allowing
Rivers to sell its interests in TerrAscend, Tweed Tree Lot, and Vert Mirabel to Canopy Growth at implied total transaction value of approximately $297 million, representing an aggregate ROIC of approximately 5.6x and IRR of approximately 101%
Dec 21, 2020 08:00 am ET
Canopy Rivers to Monetize Certain Portfolio Assets for Total Transaction Value of Approximately $297 Million and Eliminate Dual Class Share Structure Pursuant to Agreement with Canopy Growth, Allowing
Rivers to sell its interests in TerrAscend, Tweed Tree Lot, and Vert Mirabel to Canopy Growth at implied total transaction value of approximately $297 million, representing an aggregate ROIC of approximately 5.6x and IRR of approximately 101%
Dec 18, 2020 04:00 pm ET
Canopy Rivers Provides Update on PharmHouse Sale and Investment Solicitation Process, Debtor-in-Possession Financing
TORONTO, Dec. 18, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers'' or the "Company") (TSX: RIV) (OTC: CNPOF) today provided an update on its 49%-owned joint venture, PharmHouse Inc. ("PharmHouse").
Dec 18, 2020 04:00 pm ET
Canopy Rivers Provides Update on PharmHouse Sale and Investment Solicitation Process, Debtor-in-Possession Financing
TORONTO, Dec. 18, 2020 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers'' or the "Company") (TSX: RIV) (OTC: CNPOF) today provided an update on its 49%-owned joint venture, PharmHouse Inc. ("PharmHouse").
Dec 03, 2020 04:00 pm ET
Canopy Rivers Provides Update on TerrAscend, YSS, and Dynaleo
TORONTO, Dec. 3, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV) (OTC: CNPOF) today provided an update on three portfolio companies.
Dec 03, 2020 04:00 pm ET
Canopy Rivers Provides Update on TerrAscend, YSS, and Dynaleo
TORONTO, Dec. 3, 2020 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV) (OTC: CNPOF) today provided an update on three portfolio companies.
Nov 09, 2020 06:00 am ET
Canopy Rivers reports second quarter fiscal year 2021 financial results
Aggregate charges of $112.3 million recognized on PharmHouse investments
Nov 09, 2020 06:00 am ET
Canopy Rivers reports second quarter fiscal year 2021 financial results
Aggregate charges of $112.3 million recognized on PharmHouse investments
Nov 02, 2020 05:26 pm ET
Canopy Rivers Sets Filing Date for Q2 Fiscal Year 2021 Financial Results
TORONTO, Nov. 2, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will report its second quarter fiscal year 2021 financial results before markets open on November 9, 2020. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis of financial results for the three and six months ended September 30, 2020 will be available on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/investo
Nov 02, 2020 05:26 pm ET
Canopy Rivers Sets Filing Date for Q2 Fiscal Year 2021 Financial Results
TORONTO, Nov. 2, 2020 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will report its second quarter fiscal year 2021 financial results before markets open on November 9, 2020. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis of financial results for the three and six months ended September 30, 2020 will be available on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/
Oct 29, 2020 05:15 pm ET
PharmHouse Begins Sale and Investor Solicitation Process
TORONTO, Oct. 29, 2020 /CNW/ - PharmHouse Inc. ("PharmHouse"), Canopy Rivers Inc.'s ("Canopy Rivers") (TSX: RIV) (OTC: CNPOF) 49%-owned joint venture, has received approval from the Ontario Superior Court of Justice to commence its Sale and Investor Solicitation Process ("SISP"). The SISP is intended to solicit interest in, and opportunities for, a sale of, or investment in, all or part of PharmHouse's assets or business. This may include a restructuring, recapitalization, or other form of reorganization of PharmHouse's business and affairs.
Oct 09, 2020 07:00 am ET
Canopy Rivers Portfolio Companies Expanding U.S. Offerings
Update on TerrAscend, High Beauty, and Headset
Sep 24, 2020 08:38 pm ET
Canopy Rivers Announces Results of Annual General and Special Meeting of Shareholders
Asha Daniere appointed Chair, Constellation Brands' CFO Garth Hankinson elected to Board of Directors
Sep 14, 2020 07:00 am ET
Canopy Rivers Announces Receipt of Statement of Claim in Respect of Pharmhouse Joint Venture
TORONTO, Sept. 14, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") announced that it has received a statement of claim (the "Claim") filed by 2615975 Ontario Inc., the Company's joint venture partner in PharmHouse Inc. ("PharmHouse"), concerning certain disputes relating to PharmHouse. The Claim makes a number of allegations against the Company, Canopy Growth Corporation ("Canopy Growth"), and TerrAscend Corp. and TerrAscend Canada Inc. (together, "TerrAscend"), including claims relating to bad faith, fraud, civil conspiracy, breach of the duty of honesty and good faith in
Aug 18, 2020 07:00 am ET
Canopy Rivers Announces AGM Date
TORONTO, Aug. 18, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) will hold its annual general and special meeting (the "Meeting") of shareholders of the Company ("Shareholders") on September 24, 2020 at 10 a.m. (EDT). Electronic copies of all materials related to the Meeting can be found on the Company's profile on the System for Electronic Document Analysis and Retrieval or on its website at www.canopyrivers.com/investors.
Aug 14, 2020 07:00 am ET
Canopy Rivers Reports First Quarter Fiscal Year 2021 Financial Results
Formed Special Committee to oversee investment in PharmHouse
Jul 10, 2020 07:00 am ET
Jul 10, 2020 07:00 am ET
Jun 22, 2020 05:00 pm ET
Canopy Rivers' Portfolio Company Dynaleo Receives Health Canada Licence
TORONTO, June 22, 2020 /CNW/ - Dynaleo Inc. ("Dynaleo"), the most recent addition to Canopy Rivers Inc.'s ("Canopy Rivers") (TSX: RIV) (OTC: CNPOF) portfolio of disruptive cannabis companies, has received its Standard Processing Licence from Health Canada. This follows the completion and commissioning of Dynaleo's 27,000 square foot purpose-built facility, and is a key milestone as it aims to ramp up production of white label gummies for the Canadian recreational market. Dynaleo plans to develop and close on its existing customer pipeline that includes licensed producers and traditional cons
Jun 22, 2020 05:00 pm ET
Canopy Rivers' Portfolio Company Dynaleo Receives Health Canada Licence
TORONTO, June 22, 2020 /PRNewswire/ - Dynaleo Inc. ("Dynaleo"), the most recent addition to Canopy Rivers Inc.'s ("Canopy Rivers") (TSX: RIV) (OTC: CNPOF) portfolio of disruptive cannabis companies, has received its Standard Processing Licence from Health Canada. This follows the completion and commissioning of Dynaleo's 27,000 square foot purpose-built facility, and is a key milestone as it aims to ramp up production of white label gummies for the Canadian recreational market. Dynaleo plans to develop and close on its existing customer pipeline that includes licensed producers and tradition
Jun 15, 2020 07:00 am ET
Canopy Rivers Welcomes Canopy Growth CFO Mike Lee to Board of Directors
TORONTO, June 15, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV), (OTC: CNPOF) today welcomed Canopy Growth Corporation ("Canopy Growth") (TSX: WEED), (NYSE: CGC) Chief Financial Officer Mike Lee to its Board of Directors (the "Board"). Mr. Lee joins a Board that already has executives drawn from multiple industries, a wealth of strategic industry know-how, and significant public company governance experience. The Company expects that Mr. Lee's experience at Canopy Growth, Constellation Brands, Inc. ("Constellation Brands"), and other leading consumer packaged
Jun 15, 2020 07:00 am ET
Canopy Rivers Welcomes Canopy Growth CFO Mike Lee to Board of Directors
TORONTO, June 15, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF) today welcomed Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NYSE: CGC) Chief Financial Officer Mike Lee to its Board of Directors (the "Board"). Mr. Lee joins a Board that already has executives drawn from multiple industries, a wealth of strategic industry know-how, and significant public company governance experience. The Company expects that Mr. Lee's experience at Canopy Growth, Constellation Brands, Inc. ("Constellation Brands"), and other leading consumer packaged go
Jun 15, 2020 07:00 am ET
Canopy Rivers Welcomes Canopy Growth CFO Mike Lee to Board of Directors
TORONTO, June 15, 2020 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV), (OTC: CNPOF) today welcomed Canopy Growth Corporation ("Canopy Growth") (TSX: WEED), (NYSE: CGC) Chief Financial Officer Mike Lee to its Board of Directors (the "Board"). Mr. Lee joins a Board that already has executives drawn from multiple industries, a wealth of strategic industry know-how, and significant public company governance experience. The Company expects that Mr. Lee's experience at Canopy Growth, Constellation Brands, Inc. ("Constellation Brands"), and other leading consumer pa
Jun 03, 2020 07:00 am ET
Canopy Rivers Reports Fourth Quarter and Fiscal Year 2020 Financial Highlights
Strong financial position with $47 million cash on hand and no debt
Jun 03, 2020 07:00 am ET
Canopy Rivers Reports Fourth Quarter and Fiscal Year 2020 Financial Highlights
Strong financial position with $47 million cash on hand and no debt
May 28, 2020 07:00 am ET
Canopy Rivers Announces Organizational Changes to Streamline Operations
Changes are focused on cost reduction and cash generation to enhance long-term shareholder value
May 28, 2020 07:00 am ET
Canopy Rivers Announces Organizational Changes to Streamline Operations
Changes are focused on cost reduction and cash generation to enhance long-term shareholder value
May 26, 2020 07:00 am ET
Canopy Rivers Updates Date for Reporting Fourth Quarter and Fiscal Year 2020 Financial Results
TORONTO, May 26, 2020 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2020 before markets open on Wednesday, June 3, 2020. The Company's audited consolidated financial statements and management's discussion and analysis for the three and twelve months ended March 31, 2020 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.canopyrivers.com/investors.
May 26, 2020 07:00 am ET
Canopy Rivers Updates Date for Reporting Fourth Quarter and Fiscal Year 2020 Financial Results
TORONTO, May 26, 2020 /PRNewswire/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2020 before markets open on Wednesday, June 3, 2020. The Company's audited consolidated financial statements and management's discussion and analysis for the three and twelve months ended March 31, 2020 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.canopyrivers.com/investors.
May 11, 2020 07:00 am ET
Canopy Rivers to Report Fourth Quarter and Fiscal Year 2020 Financial Results
TORONTO, May 11, 2020 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2020 before markets open on Friday, May 29, 2020. The Company's audited consolidated financial statements and management's discussion and analysis for the three and twelve months ended March 31, 2020 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.canopyrivers.com/investors.
May 11, 2020 07:00 am ET
Canopy Rivers to Report Fourth Quarter and Fiscal Year 2020 Financial Results
TORONTO, May 11, 2020 /PRNewswire/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF) will report its financial results for the fourth quarter and fiscal year ended March 31, 2020 before markets open on Friday, May 29, 2020. The Company's audited consolidated financial statements and management's discussion and analysis for the three and twelve months ended March 31, 2020 will be available on the Company's profile on SEDAR at www.sedar.com and on the Company's website at www.canopyrivers.com/investors.
May 04, 2020 07:00 am ET
Canopy Rivers Targets Cannabis Gummies Market With Investment in Dynaleo
Investment addresses company's expectation that gummies will become a top selling product in Canadian edibles market
May 04, 2020 07:00 am ET
Canopy Rivers Targets Cannabis Gummies Market With Investment in Dynaleo
Investment addresses company's expectation that gummies will become a top selling product in Canadian edibles market
Apr 16, 2020 07:00 am ET
Canopy Rivers' Flagship Joint Venture PharmHouse Increases Bank Debt Facility by $10 Million
TORONTO, April 16, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF) today announced that PharmHouse Inc. ("PharmHouse"), its 49%-owned joint venture in Leamington, Ontario, amended its syndicated credit facility ("Credit Facility") with the Bank of Montreal ("BMO"), as the agent and lead lender, and the Canadian Imperial Bank of Commerce and Concentra Bank (together with BMO, the "Lenders"). The amended terms of the Credit Facility (the "Amendment") provides PharmHouse with an additional $10 million of secured debt financing, representing an increase
Apr 16, 2020 07:00 am ET
Canopy Rivers' Flagship Joint Venture PharmHouse Increases Bank Debt Facility by $10 Million
TORONTO, April 16, 2020 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF) today announced that PharmHouse Inc. ("PharmHouse"), its 49%-owned joint venture in Leamington, Ontario, amended its syndicated credit facility ("Credit Facility") with the Bank of Montreal ("BMO"), as the agent and lead lender, and the Canadian Imperial Bank of Commerce and Concentra Bank (together with BMO, the "Lenders"). The amended terms of the Credit Facility (the "Amendment") provides PharmHouse with an additional $10 million of secured debt financing, representing an in
Mar 31, 2020 07:00 am ET
Canopy Rivers Announces Launch of Normal Course Issuer Bid
Bid reflects management's view that company is undervalued, belief in future growth
Mar 31, 2020 07:00 am ET
Canopy Rivers Announces Launch of Normal Course Issuer Bid
Bid reflects management's view that company is undervalued, belief in future growth
Mar 11, 2020 05:25 pm ET
Canopy Rivers Portfolio Company Secures C$80.5 Million Debt Financing Arrangement With Canopy Growth
Loan expected to provide TerrAscend Canada with additional capital to fund Canadian operations, U.S. hemp division, international expansion, and repayment of debt
Mar 02, 2020 06:30 am ET
Canopy Rivers' Pharmhouse Joint Venture Receives Milestone Licence Amendment
1.3 million sq. ft. automated facility now fully licensed
Feb 27, 2020 10:05 am ET
Rivers Rundown: Canopy Rivers' Portfolio Companies Expanding Canadian Retail Presence
Canopy Rivers published new investor presentation and provides update on Headset, YSS, and JWC
Feb 14, 2020 06:00 am ET
Canopy Rivers Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update
TORONTO, Feb. 14, 2020 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today released its financial results for the three and nine months ended December 31, 2019 ("Q3 2020"). The Company's unaudited condensed interim consolidated financial statements for Q3 2020, and its management's discussion and analysis for Q3 2020 (the "Q3 2020 MD&A"), are available under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at ww
Feb 07, 2020 06:30 am ET
Canopy Rivers Files Early Warning Report in Connection with James E. Wagner Cultivation Investment
TORONTO, Feb. 7, 2020 /CNW/ - Canopy Rivers Inc. ("CRI") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, announces that Canopy Rivers Corporation ("Canopy Rivers") subscribed for 2,380,952 units (each a "Unit") of James E. Wagner Cultivation Corporation ("JWC") (TSXV: JWCA, OTCQX: JWCAF) at a price of $0.21 per Unit for total consideration of approximately $500,000 in connection with JWC's non-brokered private placement financing (the "Offering"). Each Unit is comprised of one common share in the capital of JWC (each a "Common Share") and one-half of one Common Share
Feb 06, 2020 08:03 am ET
Rivers Rundown: Canopy Rivers' CEO Added to NCIA Board, Portfolio Companies Grow North American Footprint
Canopy Rivers provides update on High Beauty, TerrAscend, Canapar, and JWC
Feb 05, 2020 07:00 am ET
TerrAscend and Canopy Rivers Amend Terms of Loan to Comply with TSX Policies
TORONTO, Feb. 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), the first global cannabis company licensed for sales in the U.S., Canada, and the EU, announced today that the terms of its previously announced US$10 million loan (the "Loan") from Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of Canopy Rivers Inc. (TSX: RIV, OTC: CNPOF), to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly-owned subsidiary of TerrAscend, have been amended.
Feb 05, 2020 05:55 am ET
Canopy Rivers Amends Terms of Loan to TerrAscend Canada
TORONTO, Feb. 5, 2020 /CNW/ - Canopy Rivers Inc. ("CRI") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, announces that as of February 4, 2020 Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of CRI, has amended the terms of its recent US$10 million loan (the "Loan") to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly‑owned subsidiary of TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF).
Jan 24, 2020 11:48 am ET
Canopy Rivers to Report Third Quarter Fiscal Year 2020 Financial Results and Host Earnings Call
TORONTO, Jan. 24, 2020 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, will report its third quarter fiscal year 2020 financial results before markets open on Friday, February 14, 2020. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis of financial results for the nine months ended December 31, 2019 will be available on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the C
Jan 17, 2020 06:00 am ET
Rivers Rundown: Canopy Rivers Portfolio Companies Eyeing Retail Growth, Expanded U.S. Operations
Canopy Rivers provides update on High Beauty, TerrAscend, YSS, and JWC
Jan 08, 2020 06:00 am ET
Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant
BioLumic partners with JWC and Helius Therapeutics for cannabis research program
Dec 12, 2019 06:00 am ET
Rivers Rundown: Canopy Rivers Portfolio Companies Ending Year on High Note
Canopy Rivers provides update on Headset, TerrAscend, JWC, and YSS
Nov 26, 2019 06:00 am ET
Kevin Durant's Thirty Five Ventures Joins Canopy Rivers' Strategic Advisory Board
Advisory board role marks star-backed venture firm's first exposure to Canadian cannabis sector
Nov 21, 2019 08:43 am ET
Rivers Rundown: Canopy Rivers Portfolio Companies Expand Operations, Leadership
Canopy Rivers provides update on Headset, TerrAscend, JWC, and YSS
Nov 14, 2019 06:00 am ET
Canopy Rivers Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update
TORONTO, Nov. 14, 2019 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today released its financial results for the three and six months ended September 30, 2019 ("Q2 2020"). The Company's unaudited condensed interim consolidated financial statements for Q2 2020, and its management's discussion and analysis for Q2 2020 (the "Q2 2020 MD&A"), are available under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at ww
Nov 14, 2019 06:00 am ET
Canopy Rivers Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Corporate Update
TORONTO, Nov. 14, 2019 /PRNewswire/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today released its financial results for the three and six months ended September 30, 2019 ("Q2 2020"). The Company's unaudited condensed interim consolidated financial statements for Q2 2020, and its management's discussion and analysis for Q2 2020 (the "Q2 2020 MD&A"), are available under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's websit
Nov 07, 2019 10:47 am ET
Rivers Rundown: Canopy Rivers Portfolio Companies Prepare for Cannabis 2.0
Canopy Rivers provides update on TerrAscend, JWC, and Radicle
Nov 07, 2019 10:47 am ET
Rivers Rundown: Canopy Rivers Portfolio Companies Prepare for Cannabis 2.0
Canopy Rivers provides update on TerrAscend, JWC, and Radicle
Oct 24, 2019 07:00 am ET
Canopy Rivers Portfolio Company Awarded Health Canada Oil Licence
TORONTO, Oct. 24, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company Radicle Medical Marijuana Inc. ("Radicle") has received approval for oil sales from Health Canada. This additional licence allows for the development and sale of new cannabis products, including cannabis oil and concentrates.  This opens the door for Radicle's medical patients to access other product forms in the company's craft cannabis selection.
Oct 24, 2019 07:00 am ET
Canopy Rivers Portfolio Company Awarded Health Canada Oil Licence
TORONTO, Oct. 24, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company Radicle Medical Marijuana Inc. ("Radicle") has received approval for oil sales from Health Canada. This additional licence allows for the development and sale of new cannabis products, including cannabis oil and concentrates.  This opens the door for Radicle's medical patients to access other product forms in the company's craft cannabis selection.
Oct 23, 2019 07:00 am ET
Canopy Rivers and Kindred Launch Strategic Alliance to Elevate Products & Brands
TORONTO, Oct. 23, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, and Kindred Partners Inc. ("Kindred"), a specialty cannabis brokerage and services company, today announced a strategic alliance established to provide mutual benefits to Canopy Rivers, its portfolio companies, and Kindred.
Oct 23, 2019 07:00 am ET
Canopy Rivers and Kindred Launch Strategic Alliance to Elevate Products & Brands
TORONTO, Oct. 23, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, and Kindred Partners Inc. ("Kindred"), a specialty cannabis brokerage and services company, today announced a strategic alliance established to provide mutual benefits to Canopy Rivers, its portfolio companies, and Kindred.
Oct 21, 2019 12:05 pm ET
Canopy Rivers to Report Second Quarter Fiscal Year 2020 Financial Results and Host Earnings Call
TORONTO, Oct. 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, will report its second quarter fiscal year 2020 financial results before markets open on Thursday, November 14, 2019. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis of financial results for the six months ended September 30, 2019 will be available on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on th
Oct 21, 2019 12:05 pm ET
Canopy Rivers to Report Second Quarter Fiscal Year 2020 Financial Results and Host Earnings Call
TORONTO, Oct. 21, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, will report its second quarter fiscal year 2020 financial results before markets open on Thursday, November 14, 2019. The Company's unaudited condensed interim consolidated financial statements and management's discussion and analysis of financial results for the six months ended September 30, 2019 will be available on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com an
Oct 15, 2019 01:01 pm ET
Canopy Rivers Portfolio Company Receives Milestone Health Canada Licence Amendment
TORONTO, Oct. 15, 2019 /CNW/ - Canopy Rivers ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company James E. Wagner Cultivation Corporation ("JWC") (TSXV: JWCA, OTCQX: JWCAF) received a Health Canada licence amendment allowing for cannabis production in four new flowering rooms at its flagship facility in Kitchener, Ontario.
Oct 15, 2019 01:01 pm ET
Canopy Rivers Portfolio Company Receives Milestone Health Canada Licence Amendment
TORONTO, Oct. 15, 2019 /PRNewswire/ - Canopy Rivers ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company James E. Wagner Cultivation Corporation ("JWC") (TSXV: JWCA, OTCQX: JWCAF) received a Health Canada licence amendment allowing for cannabis production in four new flowering rooms at its flagship facility in Kitchener, Ontario.
Oct 07, 2019 02:24 pm ET
Canopy Rivers Portfolio Company Announces Significant Increase in Health Canada Licensed Infrastructure
TORONTO, Oct. 7, 2019 /CNW/ - Canopy Rivers Inc. (the "Canopy Rivers") (TSX: RIV, OTC: CNPOF) today announced that its portfolio company, TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF) has received approval from Health Canada for a significant expansion at its Mississauga, Ontario facility. TerrAscend expects that this milestone will help the company meet the increased consumer demand for premium cannabis products and brands coming with the next wave of Canadian cannabis legalization. As the first and only cannabis company with sales in Canada, the U.S., and Europe, TerrAscend has
Oct 07, 2019 02:24 pm ET
Canopy Rivers Portfolio Company Announces Significant Increase in Health Canada Licensed Infrastructure
TORONTO, Oct. 7, 2019 /PRNewswire/ - Canopy Rivers Inc. (the "Canopy Rivers") (TSX: RIV, OTC: CNPOF) today announced that its portfolio company, TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF) has received approval from Health Canada for a significant expansion at its Mississauga, Ontario facility. TerrAscend expects that this milestone will help the company meet the increased consumer demand for premium cannabis products and brands coming with the next wave of Canadian cannabis legalization. As the first and only cannabis company with sales in Canada, the U.S., and Europe, TerrAsce
Oct 07, 2019 09:00 am ET
TMX Group Equity Financing Statistics - September 2019
Toronto Stock Exchange, TSX Venture Exchange
Oct 03, 2019 07:00 am ET
Canopy Rivers Invests In TerrAscend
TORONTO, Oct. 3, 2019 /CNW/ - Canopy Rivers Inc. (the "Company") announces that, in connection with a financing announced by TerrAscend Corp. ("TerrAscend") on October 2, 2019, its wholly owned subsidiary Canopy Rivers Corporation ("Canopy Rivers") has acquired ownership and control over (i) $13,243,000 principal amount of unsecured convertible debentures of TerrAscend Canada Inc. (the "Debentures"); and (ii) 333,723 common share purchase warrants of TerrAscend (the "Warrants").
Oct 02, 2019 07:00 am ET
Canopy Rivers Invests Additional US $10 Million in TerrAscend
TORONTO, Oct. 2, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, has completed a US $10 million investment (the "Investment") in TerrAscend Canada Inc. ("TerrAscend Canada"), a subsidiary of its portfolio company TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF). The investment includes the purchase of 13,243 units, with each unit consisting of: (i) one unsecured convertible debenture of TerrAscend Canada with a principal amount of CA $1,000 (the "Debentures"), and (ii) 25.2 common share purchase warrants of Te
Oct 02, 2019 07:00 am ET
Canopy Rivers Invests Additional US $10 Million in TerrAscend
TORONTO, Oct. 2, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF), a venture capital firm specializing in cannabis, has completed a US $10 million investment (the "Investment") in TerrAscend Canada Inc. ("TerrAscend Canada"), a subsidiary of its portfolio company TerrAscend Corp. ("TerrAscend") (CSE: TER, OTCQX: TRSSF). The investment includes the purchase of 13,243 units, with each unit consisting of: (i) one unsecured convertible debenture of TerrAscend Canada with a principal amount of CA $1,000 (the "Debentures"), and (ii) 25.2 common share purchase warrant
Sep 26, 2019 03:33 pm ET
Canopy Rivers Inc. announces results of annual general and special meeting of shareholders
TORONTO, Sept. 26, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the voting results from its annual general and special meeting of shareholders (the "Meeting") held today.
Sep 26, 2019 03:33 pm ET
Canopy Rivers Inc. announces results of annual general and special meeting of shareholders
TORONTO, Sept. 26, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the voting results from its annual general and special meeting of shareholders (the "Meeting") held today.
Sep 24, 2019 10:57 am ET
Canopy Rivers Inc. Opens the Market
TORONTO, Sept. 24, 2019 /CNW/ - Narbe Alexandrian, President & Chief Executive Officer, Canopy Rivers Inc. (RIV), joined Rob Peterman, Vice-President, Global Business Development, Toronto Stock Exchange & TSX Venture Exchange, to open the market. Canopy Rivers is an investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers Inc. graduated and commenced trading on Toronto Stock Exchange on September 9, 2019.
Sep 17, 2019 08:00 am ET
Investor Ideas Potcast- Cannabis News and Stocks on the Move; You Can’t Keep a Good Plant Down- Thought Leaders Share High Expectations for Cannabis Sector
Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca, release a special edition of the daily cannabis potcast (podcast), featuring a series of recent interviews...
Sep 17, 2019 07:00 am ET
Canopy Rivers Portfolio Company Licenses Leading Medical Cannabis Vape Technology in Canada
TORONTO, Sept. 17, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to announce its portfolio company, TerrAscend Corp. ("TerrAscend") (CSE: TER) (OTCQX: TRSSF), has entered into a distribution agreement with Syqe Medical, Ltd. ("Syqe"), an Israel-based pharma-tech company, to launch Syqe's flagship product, the Syqe™ Inhaler, in Canada.
Sep 17, 2019 07:00 am ET
Canopy Rivers Portfolio Company Licenses Leading Medical Cannabis Vape Technology in Canada
TORONTO, Sept. 17, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to announce its portfolio company, TerrAscend Corp. ("TerrAscend") (CSE: TER) (OTCQX: TRSSF), has entered into a distribution agreement with Syqe Medical, Ltd. ("Syqe"), an Israel-based pharma-tech company, to launch Syqe's flagship product, the Syqe™ Inhaler, in Canada.
Sep 11, 2019 07:00 am ET
Canopy Rivers Launches Strategic Advisory Board
TORONTO, Sept. 11, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to announce the formation of its Strategic Advisory Board, a group of respected business leaders that will provide guidance to Canopy Rivers' executive team as it continues to build and strengthen the Company's global portfolio of leading cannabis companies.
Sep 11, 2019 07:00 am ET
Canopy Rivers Launches Strategic Advisory Board
TORONTO, Sept. 11, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to announce the formation of its Strategic Advisory Board, a group of respected business leaders that will provide guidance to Canopy Rivers' executive team as it continues to build and strengthen the Company's global portfolio of leading cannabis companies.
Sep 10, 2019 07:00 am ET
Canopy Rivers Portfolio Company Herbert Works Awarded R&D Licence from Health Canada to Develop Cannabis-Infused Beverages
TORONTO, Sept. 10, 2019 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to share that its portfolio company Herbert Works Ltd. ("Herbert Works") has received its research and development (R&D) licence from Health Canada to develop branded cannabis-infused beverages.
Sep 10, 2019 07:00 am ET
Canopy Rivers Portfolio Company Herbert Works Awarded R&D Licence from Health Canada to Develop Cannabis-Infused Beverages
TORONTO, Sept. 10, 2019 /PRNewswire/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to share that its portfolio company Herbert Works Ltd. ("Herbert Works") has received its research and development (R&D) licence from Health Canada to develop branded cannabis-infused beverages.
Sep 10, 2019 07:00 am ET
ZeaKal Prepares for Global Growth as Ag Industry Luminary Joins Company
SAN DIEGO, Sept. 10, 2019 /PRNewswire/ -- ZeaKal, a plant traits innovator focused on improving crop efficiency, is aggressively expanding to meet the global demand for more sustainable agriculture. Building on recent collaborations with Canopy Rivers Inc. (TSXV: RIV, OTC: CNPOF) and Corteva Agriscience (NYSE:CTVA), the company today announced the close of its Series C financing round and the addition of Paul Schickler, former president of DuPont Pioneer, to its leadership team.
Sep 09, 2019 07:00 am ET
Canopy Rivers Begins Trading on the Toronto Stock Exchange
TORONTO, Sept. 9, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to announce that, as of the opening of the markets today, its class A subordinated voting shares will begin trading on the Toronto Stock Exchange (the "TSX") under the ticker symbol "RIV". This milestone was achieved within less than one year of Canopy Rivers' initial go-public transaction. No further action is required by existing shareholders.
Sep 09, 2019 07:00 am ET
Canopy Rivers Begins Trading on the Toronto Stock Exchange
TORONTO, Sept. 9, 2019 /PRNewswire/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to announce that, as of the opening of the markets today, its class A subordinated voting shares will begin trading on the Toronto Stock Exchange (the "TSX") under the ticker symbol "RIV". This milestone was achieved within less than one year of Canopy Rivers' initial go-public transaction. No further action is required by existing shareholders.
Sep 05, 2019 05:00 pm ET
Canopy Rivers Announces Trading Date On The Toronto Stock Exchange
TORONTO, Sept. 5, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, is pleased to announce that it has received final approval to list its class A subordinated voting shares (the "Subordinated Voting Shares") on the Toronto Stock Exchange (the "TSX").